bismuth has been researched along with Irritable Bowel Syndrome in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Giddings, SL; Leung, DT; Stevens, AM | 1 |
Agafonova, NA; Aldiiarova, MA; D'iachkoava, AV; Davletshina, IV; Gioeva, IZ; Iakovenko, AV; Iakovenko, EP; Ivanov, AN; Kolganova, AV; Nazarbekova, RS; Ovchinnikova, NI; Pokhal'skaia, OIu; Popova, EV; Prianishnikova, AS | 1 |
1 review(s) available for bismuth and Irritable Bowel Syndrome
Article | Year |
---|---|
Traveler's Diarrhea.
Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Antidiarrheals; Arthritis, Reactive; Bismuth; Dehydration; Diarrhea; Female; Fluid Therapy; Foodborne Diseases; Guillain-Barre Syndrome; Humans; Immunocompromised Host; Irritable Bowel Syndrome; Organometallic Compounds; Pregnancy; Probiotics; Risk Factors; Salicylates; Travel; Travel Medicine; Vaccines; Waterborne Diseases | 2016 |
1 trial(s) available for bismuth and Irritable Bowel Syndrome
Article | Year |
---|---|
[The use of bismuth tripotassium dicitrate (De-Nol), a promising line of pathogenetic therapy for irritated bowel syndrome with diarrhea].
Topics: Adolescent; Adult; Anti-Infective Agents; Bismuth; Diarrhea; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Intestinal Mucosa; Irritable Bowel Syndrome; Male; Middle Aged; Organometallic Compounds; Propylamines; Prospective Studies; Treatment Outcome; Young Adult | 2008 |